Recent Updates
Recently added Catalysts
ECOR Positive Sentiment Score: 70/100

electroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum

Tuesday, November 7, 2023 1 min read
Key Takeaway: electroCore, Inc. has announced that its CEO, Dan Goldberger, will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023. The event will be held at the Westin NY Grand Central, where electroCore will also facilitate 1x1 investor meetings. The company specializes in bioelectronic medicine, particularly using non-invasive vagus nerve stimulation to enhance wellbeing.

Market Sentiment Analysis

POSITIVE FACTORS

  • Company's CEO scheduled to present at a prominent investor forum.
  • Opportunity for 1x1 investor meetings, indicating investor interest.
  • Focus on innovative bioelectronic medicine and wellness technologies.

Full Press Release Details

ROCKAWAY, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, is scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum taking place at the Westin NY Grand Central on November 16, 2023.
electroCore will host 1x1 investor meetings on November 16, 2023. Please contact your Canaccord representative to schedule a 1x1 meeting.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
ECOR Investor Relations
investors@electrocore.com

Tags

Frequently Asked Questions

What is electroCore, Inc. known for?

electroCore, Inc. specializes in bioelectronic medicine using non-invasive vagus nerve stimulation.

When is the Canaccord Genuity Forum taking place?

The forum is scheduled for November 16, 2023, at the Westin NY Grand Central.

Who is attending the Canaccord Genuity Forum?

Dan Goldberger, CEO of electroCore, will attend the forum.

How can investors schedule meetings with electroCore?

Investors can contact their Canaccord representative to arrange 1x1 meetings.

What is the focus of electroCore's technology?

The focus is on commercializing nVNS devices for managing medical conditions and wellness.

Tags: ECOR Viatris Investor Conferences Healthcare electroCore bioelectronic medicine investor meetings nVNS technology
Last updated: Nov 7, 2023